Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Castle Biosciences to Release Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call on Tuesday, Feb. 28, 2023


Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the fourth quarter and year ended Dec. 31, 2022, after the close of market on Tuesday, Feb. 28, 2023.

Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m. Eastern time on the same day.

Conference Call and Webcast Details

A live webcast of the conference call can be accessed here: https://events.q4inc.com/attendee/697513364 or via the webcast link on the Investor Relations page of the Company's website: https://ir.castlebiosciences.com/overview/default.aspx. Please access the webcast at least 10 minutes before the conference call start time. A replay of the webcast will be available following the conclusion of the conference call.

To access the live conference call via phone, please dial 1 844 200 6205 from the United States, or +1 929 526 1599 internationally, at least 10 minutes prior to the start of the call, using the access code 235869.

There will be a brief Question & Answer session following management commentary.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.

Castle's current portfolio consists of tests for skin cancers, uveal melanoma, Barrett's esophagus and mental health conditions. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to predict systemic therapy response in patients with moderate-to-severe psoriasis, atopic dermatitis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, Twitter and Instagram.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, DecisionDx-UM, DecisionDx-PRAME, DecisionDx-UMSeq, TissueCypher and IDgenetix are trademarks of Castle Biosciences, Inc.


These press releases may also interest you

at 08:33
Making Open Source Truly Open
Semut is thrilled to announce its upcoming Developer Preview, inviting developers worldwide to join the waitlist and experience Semut's groundbreaking technologies first-hand. Interested developers can sign up for an early preview at...

at 05:45
Phoenix New Media Announces Change of Chief Executive Officer
Phoenix New Media Limited ("Phoenix New Media," "ifeng" or the "Company") , a leading new media company in China, today announced that Mr. Yusheng Sun has replaced Mr. Shuang Liu as the chief executive officer of the Company (the "CEO"). Mr. Shuang...

at 05:00
New Cryptocurrency BASALTCOIN set to Launch with a Mission to Revolutionize the Greentech Industry
BASALTCOIN, the revolutionary new cryptocurrency, is launching on March 26, 2023, with a mission to change the world and better humanity. This unique cryptocurrency is poised to revolutionize the greentech industry by commercializing intellectual...

at 03:20
Aden Financial, a cross-border OTC E-trading platform for RMB assets, raises multi-million dollar in Series A funding, led by Eight Roads Ventures
Aden Financial ("Aden"), a cross-border OTC assets E-trading platform for RMB assets, has raised multi-million dollar in Series A funding, led by Eight Roads Ventures ("Eight Roads"). As Aden's first round of external fundraising, the proceeds will...

at 02:26
Appy Pie Design Announces AI Photo Enhancer
Appy Pie Design, the online graphic design software has launched AI Photo Enhancer - an AI-powered platform that enhances the quality of images, making them visually striking and appealing....

at 01:42
On the Hungaroring, Yadea Unveiled Its High-Performance Electric Motorcycles to Appeal to a Green and Low-Carbon Lifestyle
Yadea (01585.HK), the world's leading electric two-wheeler brand, is excited to announce its first Test Ride event at the renowned Hungaroring circuit in Hungary, which gave attendees the opportunity to experience Yadea's latest models and get a feel...

More news about Science and technology...


News published on 7 february 2023 at 17:05 and distributed by: